Copanlisib in patients with relapsed or refractory indolent B-cell lymphoma: Primary results of the pivotal Chronos-1 study

被引：1
|
作者：
Dreyling, Martin
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit
Ozcan, Muhit
Kosinova, Marina
Bouabdallah, Krimo
Morschhauser, Franck
Stevens, Don A.
Trevarthen, David
Giurescu, Marius
Kupit, Lisa
Yin, Shuxin
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT149
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Phase 1 clinical study ofAtacicept in patients with relapsed and refractory B-cell lymphoma.
    Ansell, Stephen
    Witzig, Thomas E.
    Novak, Anne
    Inwards, David James
    Porrata, Luis
    Ythier, A.
    Ferrande, L.
    Nestorov, I.
    DeVries, T.
    Sievers, Eric
    BLOOD, 2006, 108 (11) : 770A - 770A
  • [32] Erratum: Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
    H Saito
    D Maruyama
    A M Maeshima
    S Makita
    H Kitahara
    K Miyamoto
    S Fukuhara
    W Munakata
    T Suzuki
    Y Kobayashi
    H Taniguchi
    K Tobinai
    Blood Cancer Journal, 2017, 7 : e620 - e620
  • [33] Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
    Tobinai, Kensei
    Watanabe, Takashi
    Ogura, Michinori
    Morishima, Yasuo
    Hotta, Tomomitsu
    Ishizawa, Kenichi
    Itoh, Kuniaki
    Okamoto, Shin-ichiro
    Taniwaki, Masafumi
    Tsukamoto, Norifumi
    Okumura, Hirokazu
    Terauchi, Takashi
    Nawano, Shigeru
    Matsusako, Masaki
    Matsuno, Yoshihiro
    Nakamura, Shigeo
    Mori, Shigeo
    Ohashi, Yasuo
    Hayashi, Masaki
    Endo, Keigo
    CANCER SCIENCE, 2009, 100 (01) : 158 - 164
  • [34] Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
    Armand, Philippe
    Rodig, Scott
    Melnichenko, Vladimir
    Thieblemont, Catherine
    Bouabdallah, Kamal
    Tumyan, Gayane
    Ozcan, Muhit
    Portino, Sergio
    Fogliatto, Laura
    Caballero, Maria D.
    Walewski, Jan
    Gulbas, Zafer
    Ribrag, Vincent
    Christian, Beth
    Perini, Guilherme Fleury
    Salles, Gilles
    Svoboda, Jakub
    Zain, Jasmine
    Patel, Sanjay
    Chen, Pei-Hsuan
    Ligon, Azra H.
    Ouyang, Jing
    Neuberg, Donna
    Redd, Robert
    Chatterjee, Arkendu
    Balakumaran, Arun
    Orlowski, Robert
    Shipp, Margaret
    Zinzani, Pier Luigi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (34) : 3291 - +
  • [35] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
  • [36] Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study
    Dickinson, Michael
    Carlo-Stella, Carmelo
    Morschhauser, Franck
    Bachy, Emmanuel
    Corradini, Paolo
    Iacoboni, Gloria
    Khan, Cyrus
    Wrobel, Thomasz
    Offner, Fritz
    Trneny, Marek
    Wu, Shang-Ju
    Cartron, Guillaume
    Hertzberg, Mark
    Sureda, Anna
    Perez-Callejo, David
    Lundberg, Linda
    Relf, James
    Clark, Emma
    Humphrey, Kathryn
    Hutchings, Martin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S435 - S435
  • [37] Glofitamab in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma and ≥2 Prior Therapies: Results from a Pivotal Phase II Expansion Study
    Michael, Dickinson
    Carmelo, Carlo-Stella
    Franck, Morschhauser
    Emmanuel, Bachy
    Paolo, Corradini
    Gloria, Iacoboni
    Cyrus, Khan
    Tomasz, Wrobel
    Fritz, Offner
    Marek, Trneny
    Shang-Ju, Wu
    Guillaume, Cartron
    Mark, Hertzberg
    Anna, Sureda
    David, Perez-Callejo
    Linda, Lundberg
    James, Relf
    Emma, Clark
    Kathryn, Humphrey
    Martin, Hutchings
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S39 - S40
  • [38] Radioimmunotherapy for Indolent B-Cell Non-Hodgkin Lymphoma in Relapsed, Refractory and Transformed Disease
    Otto J. Visser
    Lars R. Perk
    Josée M. Zijlstra
    Guus A.M.S. van Dongen
    Peter C. Huijgens
    Arjan A. van de Loosdrecht
    BioDrugs, 2006, 20 : 201 - 207
  • [39] Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease
    Visser, Otto J.
    Perk, Lars R.
    Zijlstra, Josee M.
    van Dongen, Guus A. M. S.
    Huijgens, Peter C.
    van de Loosdrecht, Arjan A.
    BIODRUGS, 2006, 20 (04) : 201 - 207
  • [40] Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
    Kim, Seok Jin
    Kang, Hye Jin
    Shin, Dong-Yeop
    Yoon, Dok Hyun
    Sakamoto, Kana
    Kong, Jee Hyun
    Ko, Young Hyeh
    Takeuchi, Kengo
    Suh, Cheolwon
    Kim, Won Seog
    BLOOD, 2014, 124 (21)
12345